Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies

Matteo Nicola Dario Di Minno,Giacomo Emmi,Pasquale Ambrosino,Antonella Scalera,Antonella Tufano,Giovanni Cafaro,Rosario Peluso,Alessandra Bettiol,Gerardo Di Scala,Elena Silvestri,Domenico Prisco

doi:10.1016/j.dib.2018.06.083

Matteo Nicola Dario Di Minno, Giacomo Emmi + Show 9 more

Open Access

https://doi.org/10.1016/j.dib.2018.06.083

Copy DOI

Abstract

Whereas some previous data on carriers with isolated antiphospholipid antibodies positivity (APP) suggested an increased risk of arterial events in this clinical setting, no data are available on subclinical atherosclerosis in this clinical setting. This article reports data on intima-media thickness of the common carotid artery (CCA-IMT) and of the Bulb (Bulb-IMT) and on the prevalence of carotid plaques in APP carriers and in subjects with antiphospholipid syndrome (APS) specifically stratifying for the presence of thrombotic manifestations, cardiovascular risk factors, antibody isotype and concomitant Systemic Lupus Erythematosus (SLE) or other autoimmune diseases.

Highlights

Whereas some previous data on carriers with isolated antiphospholipid antibodies positivity (APP) suggested an increased risk of arterial events in this clinical setting, no data are available on subclinical atherosclerosis in this clinical setting
Medicine Vascular medicine Common carotid artery intima-media thickness (CCA-IMT), intimamedia thickness at the level of carotid Bulb (Bulb-IMT) and prevalence of carotid plaques in subjects with antiphospholipid syndrome (APS), in carriers with isolated antiphospholipid antibodies positivity (APP) and controls stratified for the presence of thrombotic manifestations and cardiovascular risk factors, antibody isotype and Systemic Lupus Erythematosus (SLE) or other autoimmune diseases Ultrasound machine (MyLab 25 Gold, Esaote, Florence, Italy) with a 7.5–12 MHz linear-array transducer
APS subjects with non-arterial thrombotic events showed a more severe atherosclerosis than controls, whereas no difference was found as compared to APP carriers (Table 1)

Summary

Effect of different types of thrombotic events on subclinical atherosclerosis

APS subjects with arterial thrombotic manifestations showed the highest CCA-IMT and Bulb-IMT values, and the highest prevalence of carotid plaques. The difference was significant both versus controls and versus APP carriers. APS subjects with non-arterial thrombotic events (including venous thrombosis and recurrent miscarriage) showed a more severe atherosclerosis than controls, whereas no difference was found as compared to APP carriers (Table 1)

Effect of cardiovascular risk factors on subclinical atherosclerosis

Effect of co-existing auto-immunity disorders on subclinical atherosclerosis